We are live on
!
Find out more
CC
Capital Counsel Portfolio holdings
AUM
$2.56B
1-Year Est. Return
28.38%
This Fund
S&P 500
This Quarter
Est. Return
+9.55%
1 Year Est. Return
+28.38%
3 Year Est. Return
+94.92%
5 Year Est. Return
+110.58%
10 Year Est. Return
+559.62%
AUM
$2.13B
AUM Growth
+$351M
(+20%)
Cap. Flow
+$195M
Cap. Flow
% of AUM
9.15%
Top 10 Holdings %
Top 10 Hldgs %
57.71%
Holding
137
New
6
Increased
26
Reduced
40
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CDK
CDK Global, Inc.
CDK
|
+$60.3M |
| 2 |
Ecolab
ECL
|
+$33.8M |
| 3 |
Visa
V
|
+$26.1M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$4.2M |
| 5 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$3.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Core Laboratories
CLB
|
+$39.2M |
| 2 |
Automatic Data Processing
ADP
|
+$21.4M |
| 3 |
FEIC
FEI COMPANY
FEIC
|
+$20.5M |
| 4 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$17.9M |
| 5 |
WEX
WEX
|
+$6.98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.44% |
| 2 | Industrials | 23.8% |
| 3 | Miscellaneous | 15.29% |
| 4 | Financials | 11.71% |
| 5 | Technology | 10% |
Similar funds
AFP
TCAM
SCA
RT
CTA
BAM
CL
MC
Capital Counsel's Q4 2014 Portfolio in Review
As of Q4 2014, Capital Counsel held 137 positions worth $2.13B, up 20% from $1.78B the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Capital Counsel deployed $195M of net new capital in Q4 2014, opening 6 new positions and adding to 26 existing holdings. Its largest new stake was CDK Global, Inc.: 1,701,952 shares worth $69.4M.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 31% a quarter earlier, followed by Industrials and Miscellaneous.
On the sell side, the largest reduction was Core Laboratories, an estimated $39.2M trimmed.
- Capital Counsel's largest Q4 2014 buy was CDK Global, Inc.: 1,701,952 shares worth $69.4M.
- Capital Counsel added most to Ecolab in Q4 2014, an estimated $33.8M increase.
- Capital Counsel's biggest Q4 2014 reduction was Core Laboratories, cutting an estimated $39.2M.
- Capital Counsel fully exited Fastenal in Q4 2014, selling an estimated $4.02M.
- Capital Counsel's ten largest holdings make up 58% of its $2.13B portfolio in Q4 2014.
- Capital Counsel opened 6 new positions and closed 7 in Q4 2014.
- Capital Counsel's portfolio value rose 20% quarter-over-quarter to $2.13B.
Based on Capital Counsel's 13F filing for Q4 2014, filed 11 Feb 2015.